3M Stock: It Beat Earnings and RAISED Guidance — So Why We Say HOLD

3M Company (MMM) Q2 2026 — 3M (MMM), the Post-it and Scotch-tape industrial icon, reported a clean Q2 2026 adjusted beat: adjusted EPS of $2.40 topped the ~$2.27 estimate (+11% YoY) on sales of $6.5B with adjusted organic growth of 5.4%, and adjusted operating margin rose 40 bps to 24.9%. GAAP was messier — EPS of $1.78 and a 15.1% operating margin (down 290 bps), weighed by a divestiture loss and litigation costs. Management RAISED full-year adjusted EPS guidance to $8.80–$8.95 (from $8.50–$8.70). The stock (~$173, up ~24% off its $139 low) sits near its $177 52-week high. The catch: even our turnaround-leaning DCF lands fair value near $158 — below the price, before fully charging the multi-year PFAS and earplug cash bill. Our call: HOLD. 3M is one of the great American industrial turnarounds in progress — the Post-it, Scotch-tape and respirator maker that spent years as a litigation punching bag (PFAS, Combat Arms earplugs, tens of billions in settlements) and is now, under new CEO William Brown, quietly running well again. Q2 2026 was a clean adjusted beat: adjusted EPS of $2.40 beat the ~$2.27 estimate (+11% YoY), sales of $6.5B grew 5.4% organically, and adjusted operating margin expanded 40 bps to 24.9%. GAAP told a rougher story — EPS of $1.78 and a 15.1% operating margin, down 290 bps, dragged by a divestiture loss and litigation. Safety & Industrial led with +8.2% organic growth and a 27.8% margin; Transportation & Electronics rose ~5.9%; only Consumer lagged (-1.8%). Management RAISED full-year adjusted EPS guidance to $8.80–$8.95 (from $8.50–$8.70), with adjusted FCF of $1.3B and $1.4B returned to shareholders. So the debate isn't quality — it's price. The stock has re-rated ~24% off its $139 low to ~$173, near its $177 high, at ~19x forward earnings. Even giving Brown full credit with a turnaround-compounder path AND a quality discount rate, our owner-earnings DCF lands fair value near $158 — below the price, and that already gives 3M credit before charging the real PFAS and earplug cash bill the adjusted numbers step around. A genuinely improving company with no margin of safety. Our call: HOLD, 3/5. We're a touch more cautious than the Street's split Buy (~$185 median target, +7%). Own it for the recovering quality, add on real weakness toward the mid-$150s, and watch reported free cash flow and the litigation runoff. Not financial advice. THE CALL: HOLD (3/5, A REAL TURNAROUND, FULLY PRICED — A BEAT-AND-RAISE WITH NO MARGIN OF SAFETY) — base-case value ~$158 vs ~$173 today. What to watch: durable evidence the turnaround is compounding — organic growth pushing past mid-single digits, reported (GAAP) free cash flow climbing as the PFAS and earplug settlement payments taper, and margins holding their gains — which would justify the re-rating and prompt an upgrade; the risk to respect is a fresh litigation escalation or a consumer/industrial slowdown, which at ~19x earnings with cash already bleeding to settlements could re-rate the stock hard Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.